CLINDAMYCIN PHOSPHATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for clindamycin phosphate and what is the scope of patent protection?
Clindamycin phosphate
is the generic ingredient in eighteen branded drugs marketed by Glenmark Pharms Ltd, Padagis Israel, Taro, Norvium Bioscience, Pfizer, Fougera Pharms, Padagis Us, Bausch, Alembic, Amneal, Encube, Quagen, Solaris Pharma Corp, Zydus Lifesciences, Organon Llc, Pharmacia And Upjohn, Abraxis Pharm, Almaject, Bedford, Bristol Myers Squibb, Fresenius Kabi Usa, Hikma, Igi Labs Inc, Loch, Marsam Pharms Llc, Rising, Sagent Pharms Inc, Solopak, Teva Parenteral, Watson Labs, Baxter Hlthcare Corp, Sandoz Inc, Abbott Labs, Baxter Hlthcare, Boca Pharma Llc, Chartwell Rx, Encube Ethicals, Endo Operations, Fougera Pharms Inc, G And W Labs Inc, Novast Labs, Pai Holdings Pharm, Taro Pharm Inds, Vintage Pharms, Xttrium Labs Inc, Epic Pharma Llc, Actavis Mid Atlantic, and Almirall, and is included in ninety-one NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.Clindamycin phosphate has sixty-four patent family members in twenty-five countries.
There are twenty-five drug master file entries for clindamycin phosphate. Thirty suppliers are listed for this compound.
Summary for CLINDAMYCIN PHOSPHATE
International Patents: | 64 |
US Patents: | 4 |
Tradenames: | 18 |
Applicants: | 48 |
NDAs: | 91 |
Drug Master File Entries: | 25 |
Finished Product Suppliers / Packagers: | 30 |
Raw Ingredient (Bulk) Api Vendors: | 49 |
Clinical Trials: | 30 |
Patent Applications: | 3,692 |
Drug Prices: | Drug price trends for CLINDAMYCIN PHOSPHATE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CLINDAMYCIN PHOSPHATE |
What excipients (inactive ingredients) are in CLINDAMYCIN PHOSPHATE? | CLINDAMYCIN PHOSPHATE excipients list |
DailyMed Link: | CLINDAMYCIN PHOSPHATE at DailyMed |
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Daré Bioscience, Inc. | Phase 1 |
Memorial Sloan Kettering Cancer Center | Phase 2 |
Daré Bioscience, Inc. | Phase 3 |
Pharmacology for CLINDAMYCIN PHOSPHATE
Drug Class | Lincosamide Antibacterial |
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CLINDAMYCIN PHOSPHATE
Paragraph IV (Patent) Challenges for CLINDAMYCIN PHOSPHATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
CLINDESSE | Vaginal Cream | clindamycin phosphate | 2% | 050793 | 1 | 2015-02-05 |
US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | CLEOCIN | clindamycin phosphate | CREAM;VAGINAL | 050680-001 | Aug 11, 1992 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
G And W Labs Inc | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 062811-001 | Sep 1, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Almaject | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 062801-001 | Jul 24, 1987 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Watson Labs | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 062900-001 | Jun 8, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Pai Holdings Pharm | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 206945-001 | Dec 30, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Hikma | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 063068-001 | Aug 28, 1989 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Abraxis Pharm | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% | clindamycin phosphate | INJECTABLE;INJECTION | 050635-001 | Dec 22, 1989 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CLINDAMYCIN PHOSPHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 6,899,890 | ⤷ Subscribe |
Norvium Bioscience | EVOCLIN | clindamycin phosphate | AEROSOL, FOAM;TOPICAL | 050801-001 | Oct 22, 2004 | 7,141,237 | ⤷ Subscribe |
Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 5,993,856 | ⤷ Subscribe |
Bausch | CLINDAGEL | clindamycin phosphate | GEL;TOPICAL | 050782-001 | Nov 27, 2000 | 6,387,383 | ⤷ Subscribe |
Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 5,266,329 | ⤷ Subscribe |
Pfizer | CLEOCIN | clindamycin phosphate | SUPPOSITORY;VAGINAL | 050767-001 | Aug 13, 1999 | 6,495,157 | ⤷ Subscribe |
Norvium Bioscience | EVOCLIN | clindamycin phosphate | AEROSOL, FOAM;TOPICAL | 050801-001 | Oct 22, 2004 | 7,374,747 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CLINDAMYCIN PHOSPHATE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2289512 | Mousse pharmaceutique (Pharmaceutical foam) | ⤷ Subscribe |
Argentina | 047108 | FORMULACION FARMACEUTICA PARA TRATAR AFECCIONES VAGINALES EN HUMANOS, COMPOSICION PARA TRATAR UNA INFECCION VAGINAL Y METODO PARA TRATAR DICHA INFECCION VAGINAL | ⤷ Subscribe |
Japan | 4828404 | ⤷ Subscribe | |
World Intellectual Property Organization (WIPO) | 2017015232 | ⤷ Subscribe | |
World Intellectual Property Organization (WIPO) | 2004064833 | ⤷ Subscribe | |
Serbia | 20050557 | KLINDAMICIN FOSFAT U OBLIKU PENE (CLINDAMYCIN PHOSPHATE FOAM) | ⤷ Subscribe |
Canada | 2635992 | MEDICAMENT UTILISE PAR VOIE TOPIQUE (MEDICAMENT FOR TOPICAL USE) | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CLINDAMYCIN PHOSPHATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | C01304992/01 | Switzerland | ⤷ Subscribe | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
1304992 | 92401 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
1304992 | CR 2013 00053 | Denmark | ⤷ Subscribe | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
1304992 | C300617 | Netherlands | ⤷ Subscribe | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
1304992 | SPC/GB13/061 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624 |
1304992 | 2013/044 | Ireland | ⤷ Subscribe | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
1304992 | 122013000081 | Germany | ⤷ Subscribe | PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
CLINDAMYCIN PHOSPHATE Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.